Active Filter(s):
Details:
KH-001 Besylate is a unique, proprietary on-demand drug being developed as the first FDA-approved treatment for premature ejaculation, the most common form of male sexual dysfunction.
Lead Product(s): KH-001 Besylate
Therapeutic Area: Psychiatry/Psychology Product Name: KH-001
Highest Development Status: IND Enabling Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 16, 2023